High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.7M
$3,698,072
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Betz Stephen F.
• Officer • Chief Scientific Officer
Sell to Cover
2026-03-16
$396,610x2
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-03-16 | $396,610x2 | S | Form 4 |
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-16 | $370,411x2 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Sell to Cover
2026-03-16
$821,513x2
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-16 | $821,513x2 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Vivaldi Coelho Rogerio
• Director
10b5-1 Sell
2026-03-12
$180,761x2
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-12 | $180,761x2 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Okey Stephanie
• Director
10b5-1 SellΔOwn -18.4%
2026-03-03
$119,010
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -18.4%
|
2026-03-03 | $119,010 | S | Form 4 |
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-03-03 | $266,305 | S | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Equity Compensation
2025-12-18
$585,890x4
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Equity Compensation
|
2025-12-18 | $585,890x4 | M | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
Equity Compensation
2025-12-01
$84,450x2
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
Equity Compensation
|
2025-12-01 | $84,450x2 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
10b5-1 Sell
2025-12-01
$225,100
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
10b5-1 Sell
|
2025-12-01 | $225,100 | S | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
Other
2025-11-03
$84,450
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
Other
|
2025-11-03 | $84,450 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
10b5-1 Sell
2025-11-03
$213,312x2
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
10b5-1 Sell
|
2025-11-03 | $213,312x2 | S | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
Other
2025-10-01
$84,450
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
Other
|
2025-10-01 | $84,450 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Pizzuti Dana
• Officer • Chief Med and Dev Officer
10b5-1 Sell
2025-10-01
$209,050
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Officer • Chief Med and Dev Officer
10b5-1 Sell
|
2025-10-01 | $209,050 | S | Form 4 |
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
Other
|
2025-09-26 | $19,100 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Fust Matthew K
• Director
10b5-1 SellΔOwn -41.2%
2025-09-26
$716,000
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -41.2%
|
2025-09-26 | $716,000 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
10b5-1 Sell
2025-09-26
$180,000
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2025-09-26 | $180,000 | S | Form 4 |